A panel of Clathrin Heavy Chain (CLTC), Ezrin (EZR), Talin-1 (TLN1), Adenylyl cyclase-associated protein 1 (CAP1), and Moesin (MSN) positive exosomes demonstrated 0.94–0.99 accuracy against other cancers [105]. This evidence concerns the gene CLTC and cancer.